Article
Anti-SARS-CoV2 antibody levels predict outcome in diabetic patients with COVID-19: a prospective cohort study
2023-07-17
Abstract excerpt
Diabetic patients constitute one of the most vulnerable subgroups in COVID-19. Despite high vaccination rates, a correlate of protection to advise vaccination strategies for novel SARS-CoV2 variants of concern and lower mortality in this high-risk group is still missing. It is further unclear what antibody levels provide protection and whether pre-existing organ damage affects this threshold. To address these gaps...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5a90497-b465-50f1-9728-dd67ced6cf52
- DOI
- 10.21203/rs.3.rs-3086248/v1
